NASDAQ:DNTH | Free Cash Flow | Dianthus Therapeutics, Inc. /DE/

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2016-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$28.86M
2025-12-31-$46.98M
2025-03-31-$27.63M
2024-12-31-$27.44M
2024-03-31-$14.94M
2023-12-31-$11.85M
2023-03-31-$10.28M$245,000.00-$10.53M
2022-12-31-$8.85M$0.00-$8.85M
2022-03-31-$19.74M$27,000.00-$19.77M
2021-12-31-$15.69M$15,000.00-$15.71M
2021-03-31-$16.77M$7,000.00-$16.78M
2020-12-31-$13.73M$213,000.00-$13.95M
2020-03-31-$16.66M$131,000.00-$16.79M
2019-12-31-$15.63M$153,000.00-$15.78M
2019-03-31-$14.94M$1.25M-$16.19M
2018-12-31-$12.62M$4.35M-$16.98M
2018-03-31-$9.6M$161,000.00-$9.77M
2017-12-31-$8.23M$317,000.00-$8.55M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$129.06M
2024-12-31-$78.18M
2023-12-31-$36.86M
2022-12-31-$29.07M$314,000.00-$29.38M
2021-12-31-$59.53M$1.26M-$60.8M
2020-12-31-$64.02M$400,000.00-$64.42M
2019-12-31-$57.1M$3.06M-$60.16M
2018-12-31-$41.89M$7.67M-$49.56M
2017-12-31-$22.26M$2.2M-$24.46M
2016-12-31-$6.53M$139,000.00-$6.67M